Save up to 18% vs brand
Generic Crizanlizumab in Philadelphia, Pennsylvania
Generic Crizanlizumab-tmca is FDA-approved and costs from $6970 in Philadelphia — vs $11050 for brand-name Crizanlizumab. Compare local Philadelphia pharmacies on Script Unlock.
Brand Crizanlizumab
$11050
Generic in Philadelphia
from $6970
You save
18%
Generic Crizanlizumab is FDA-Approved
- Same active ingredient as brand-name
- FDA bioequivalence verified
- Available at licensed pharmacies in Philadelphia
- No prescription change needed